These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


458 related items for PubMed ID: 25335775

  • 1. Species-specific engagement of human nucleotide oligomerization domain 2 (NOD)2 and Toll-like receptor (TLR) signalling upon intracellular bacterial infection: role of Crohn's associated NOD2 gene variants.
    Salem M, Seidelin JB, Eickhardt S, Alhede M, Rogler G, Nielsen OH.
    Clin Exp Immunol; 2015 Mar; 179(3):426-34. PubMed ID: 25335775
    [Abstract] [Full Text] [Related]

  • 2. Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways.
    Brosbøl-Ravnborg A, Hvas CL, Agnholt J, Dahlerup JF, Vind I, Till A, Rosenstiel P, Höllsberg P.
    Clin Exp Immunol; 2009 Mar; 155(3):487-95. PubMed ID: 19094116
    [Abstract] [Full Text] [Related]

  • 3. Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide.
    Coulombe F, Divangahi M, Veyrier F, de Léséleuc L, Gleason JL, Yang Y, Kelliher MA, Pandey AK, Sassetti CM, Reed MB, Behr MA.
    J Exp Med; 2009 Aug 03; 206(8):1709-16. PubMed ID: 19581406
    [Abstract] [Full Text] [Related]

  • 4. Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease.
    van Heel DA, Ghosh S, Hunt KA, Mathew CG, Forbes A, Jewell DP, Playford RJ.
    Gut; 2005 Nov 03; 54(11):1553-7. PubMed ID: 15928043
    [Abstract] [Full Text] [Related]

  • 5. MDP-Induced selective tolerance to TLR4 ligands: impairment in NOD2 mutant Crohn's disease patients.
    Cantó E, Moga E, Ricart E, Garcia-Bosch O, Garcia-Planella E, Juarez C, Vidal S.
    Inflamm Bowel Dis; 2009 Nov 03; 15(11):1686-96. PubMed ID: 19572373
    [Abstract] [Full Text] [Related]

  • 6. Mycobacterium paratuberculosis is recognized by Toll-like receptors and NOD2.
    Ferwerda G, Kullberg BJ, de Jong DJ, Girardin SE, Langenberg DM, van Crevel R, Ottenhoff TH, Van der Meer JW, Netea MG.
    J Leukoc Biol; 2007 Oct 03; 82(4):1011-8. PubMed ID: 17652449
    [Abstract] [Full Text] [Related]

  • 7. Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations.
    Li J, Moran T, Swanson E, Julian C, Harris J, Bonen DK, Hedl M, Nicolae DL, Abraham C, Cho JH.
    Hum Mol Genet; 2004 Aug 15; 13(16):1715-25. PubMed ID: 15198989
    [Abstract] [Full Text] [Related]

  • 8. Nod2 and Rip2 contribute to innate immune responses in mouse neutrophils.
    Jeong YJ, Kang MJ, Lee SJ, Kim CH, Kim JC, Kim TH, Kim DJ, Kim D, Núñez G, Park JH.
    Immunology; 2014 Oct 15; 143(2):269-76. PubMed ID: 24766550
    [Abstract] [Full Text] [Related]

  • 9. Engagement of NOD2 has a dual effect on proIL-1beta mRNA transcription and secretion of bioactive IL-1beta.
    Ferwerda G, Kramer M, de Jong D, Piccini A, Joosten LA, Devesaginer I, Girardin SE, Adema GJ, van der Meer JW, Kullberg BJ, Rubartelli A, Netea MG.
    Eur J Immunol; 2008 Jan 15; 38(1):184-91. PubMed ID: 18157816
    [Abstract] [Full Text] [Related]

  • 10. Influence of NOD-like receptor 2 gene polymorphisms on muramyl dipeptide induced pro-inflammatory response in patients with active pulmonary tuberculosis and household contacts.
    Mandala JP, Thada S, Sivangala R, Ponnana M, Myakala R, Gaddam S.
    Immunobiology; 2021 Jul 15; 226(4):152096. PubMed ID: 34058448
    [Abstract] [Full Text] [Related]

  • 11. Computational studies on receptor-ligand interactions between novel buffalo (Bubalus bubalis) nucleotide-binding oligomerization domain-containing protein 2 (NOD2) variants and muramyl dipeptide (MDP).
    Brahma B, Patra MC, Mishra P, De BC, Kumar S, Maharana J, Vats A, Ahlawat S, Datta TK, De S.
    J Mol Graph Model; 2016 Apr 15; 65():15-26. PubMed ID: 26897084
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. TLR4, IL10RA, and NOD2 mutation in paediatric Crohn's disease patients: an association with Mycobacterium avium subspecies paratuberculosis and TLR4 and IL10RA expression.
    Wagner J, Skinner NA, Catto-Smith AG, Cameron DJ, Michalski WP, Visvanathan K, Kirkwood CD.
    Med Microbiol Immunol; 2013 Aug 15; 202(4):267-76. PubMed ID: 23455702
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease.
    van Heel DA, Ghosh S, Butler M, Hunt KA, Lundberg AM, Ahmad T, McGovern DP, Onnie C, Negoro K, Goldthorpe S, Foxwell BM, Mathew CG, Forbes A, Jewell DP, Playford RJ.
    Lancet; 2013 Aug 15; 365(9473):1794-6. PubMed ID: 15910952
    [Abstract] [Full Text] [Related]

  • 16. Muramyl dipeptide responsive pathways in Crohn's disease: from NOD2 and beyond.
    Salem M, Seidelin JB, Rogler G, Nielsen OH.
    Cell Mol Life Sci; 2013 Sep 15; 70(18):3391-404. PubMed ID: 23275943
    [Abstract] [Full Text] [Related]

  • 17. Differential effect of vitamin D on NOD2- and TLR-induced cytokines in Crohn's disease.
    Dionne S, Calderon MR, White JH, Memari B, Elimrani I, Adelson B, Piccirillo C, Seidman EG.
    Mucosal Immunol; 2014 Nov 15; 7(6):1405-15. PubMed ID: 24781050
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Increased inflammatory responsiveness of peripheral blood mononuclear cells (PBMCs) to in vitro NOD2 ligand stimulation in patients with ankylosing spondylitis.
    Vanaki N, Golmohammadi T, Jamshidi A, Akhtari M, Vojdanian M, Mostafaei S, Poursani S, Ahmadzadeh N, Mahmoudi M.
    Immunopharmacol Immunotoxicol; 2018 Oct 15; 40(5):393-400. PubMed ID: 30265175
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.